HIV&COPD
Prevalencia, Factores de Riesgo y características patogénicas Diferenciales de EPOC y Enfisema en Pacientes Con infección VIH.
Sponsor study identifier
observational
350
1 country
1
Study Start
July 2008
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
January 2011
Actual (reported)Study Completion
January 2011
Actual (reported)The prevalence of COPD in HIV+ and AIDS patients is unknown. The pathophysiology of HIV infection and COPD might be of interest to both conditions. The research hypotheses of this study are: In patients with HIV infection living in the Autonomous Community of the Balearic Islands (CAIB):
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 2011
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 2008
Date type not reportedThis date has not been verified as actual or estimated.
May 15, 2009
Actual (reported)May 19, 2009
Actual (reported)January 2011
Actual (reported)January 2011
Actual (reported)Prevalence of airflow obstruction compatible with COPD in patients with HIV infection
cross-sectional
To determine the prevalence (and severity) of emphysema (HRCT)
Cross-sectional
To Identify risk factors associated with the development of COPD and / or emphysema
Cross-sectional
To analyze the predictive value of measuring DLCO as a marker of emphysema by HRCT
Cross-sectional
To determine the prevalence of lung function abnormalities deeming specific drug treatment (bronchodilators, inhaled corticosteroids) in the absence of clinical symptoms
Cross-sectional
To compare the pattern of inflammatory response in patients with COPD and / or emphysema, with and without HIV infection
Cross-sectional
Patients with HIV infection living in the Autonomous Community of the Balearic Islands (CAIB), Spain
Same determinations as in HIV+ cases will be obtained in the control group of COPD patients without HIV infection as part of the study PAC-EPOC (FIS 05/2082)
Patients will be recruited from the HIV outpatient consultation of the Internal Medicine Department of Hospital Universitario Son Dureta (HUSD), in Mallorca, Spain. The HUSD is the tertiary, reference hospital in the CAIB.
Hospital Universitario Son Dureta
Palma de Mallorca, Balearic Islands, 07014, Spain
Melchor Riera, MD
Hospital Universitario Son Dureta
First Submitted
May 15, 2009
First Posted
May 19, 2009
Study Start
July 2008
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
January 2011
Actual (reported)COPD and Cardiovascular Risk in the Population
Contact the study team to confirm eligibility.
Study Completion
January 2011
Actual (reported)Last Updated
June 10, 2011
Record last verified: 2011-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: